89bio (ETNB) Stock Chart & Stock Price History → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free ETNB Stock Alerts $9.50 +0.47 (+5.20%) (As of 09:03 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media 89bio Stock Price Performance5 Day Performance+3.04%1 Month Performance-12.84%3 Month Performance+12.43%6 Month Performance+24.35%Year-To-Date Performance-14.95%1 Year Performance-47.43% Receive ETNB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 89bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. ETNB Stock Chart for Thursday, May, 9, 2024 ETNB Chart by TradingView 89bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$9.37$9.03-3.63%$9.30$8.83553,058 shs$859.84 million05/07/2024$9.59$9.37-2.29%$9.83$9.34522,538 shs$892.21 million05/06/2024$9.22$9.59+4.01%$9.74$9.19588,563 shs$913.16 million05/03/2024$8.86$9.22+4.06%$9.35$8.90645,965 shs$877.93 million05/02/2024$8.75$8.86+1.26%$9.15$8.56588,355 shs$843.65 million05/01/2024$8.51$8.75+2.82%$9.14$8.54841,513 shs$833.18 million Get the Latest News and Ratings for ETNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 89bio and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$8.53$8.51-0.23%$8.77$8.42564,173 shs$810.32 million04/29/2024$8.26$8.53+3.27%$8.66$8.35590,480 shs$812.23 million04/26/2024$8.25$8.26+0.12%$8.45$8.18652,866 shs$786.52 million04/25/2024$8.58$8.25-3.85%$8.46$8.041.01 million shs$785.57 million04/24/2024$8.92$8.58-3.81%$9.11$8.55871,176 shs$816.99 million04/23/2024$9.31$8.92-4.19%$9.57$8.92745,413 shs$849.36 million04/22/2024$9.08$9.31+2.53%$9.78$9.12580,145 shs$886.50 million04/19/2024$8.88$9.08+2.25%$9.10$8.781.01 million shs$848.98 million04/18/2024$9.16$8.88-3.06%$9.34$8.86675,417 shs$830.28 million04/17/2024$9.37$9.16-2.24%$9.57$9.12686,353 shs$856.47 million04/16/2024$9.49$9.37-1.26%$9.56$9.25548,711 shs$876.10 million04/15/2024$9.82$9.49-3.36%$9.93$9.41670,950 shs$887.32 million04/12/2024$10.14$9.82-3.16%$10.18$9.66722,251 shs$918.18 million04/11/2024$10.54$10.14-3.80%$10.63$10.061.35 million shs$948.09 million04/10/2024$10.90$10.54-3.30%$10.60$10.341.03 million shs$985.49 million04/09/2024$10.79$10.90+1.02%$10.97$10.61614,313 shs$1.02 billion04/08/2024$10.76$10.79+0.28%$10.91$10.65337,381 shs$1.01 billion04/05/2024$10.65$10.76+1.03%$10.84$10.25408,168 shs$1.01 billion04/04/2024$10.87$10.65-2.02%$11.17$10.49887,158 shs$995.78 million04/03/2024$10.58$10.87+2.74%$10.90$10.34936,752 shs$1.02 billion04/02/2024$10.73$10.58-1.40%$10.66$10.17903,255 shs$989.23 million04/01/2024$11.64$10.73-7.82%$11.58$10.65948,482 shs$1.00 billion03/29/2024$11.64$11.64$11.69$11.01840,223 shs$1.09 billion03/28/2024$11.31$11.64+2.92%$11.68$11.03840,202 shs$1.09 billion03/27/2024$11.20$11.31+0.98%$11.62$11.001.30 million shs$1.06 billion03/26/2024$11.34$11.20-1.23%$11.62$11.18567,592 shs$1.05 billion03/25/2024$11.50$11.34-1.39%$11.73$11.32548,951 shs$1.06 billion03/22/2024$11.45$11.50+0.44%$11.89$11.37760,771 shs$1.08 billion03/21/2024$11.32$11.45+1.15%$11.88$11.36797,137 shs$1.07 billion03/20/2024$11.92$11.32-5.03%$12.16$11.101.34 million shs$1.06 billion03/19/2024$12.60$11.92-5.40%$12.54$11.861.19 million shs$1.11 billion03/18/2024$13.52$12.60-6.80%$13.69$12.571.60 million shs$1.18 billion03/15/2024$12.61$13.52+7.22%$13.55$12.674.64 million shs$1.26 billion03/14/2024$13.31$12.61-5.26%$13.33$11.861.81 million shs$1.18 billionThis 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here03/13/2024$12.87$13.31+3.42%$13.35$12.731.03 million shs$1.24 billion03/12/2024$12.89$12.87-0.16%$13.09$12.561.30 million shs$1.20 billion03/11/2024$12.93$12.89-0.31%$13.50$12.851.12 million shs$1.21 billion03/08/2024$13.02$12.93-0.69%$13.62$12.911.04 million shs$1.21 billion03/07/2024$12.13$13.02+7.34%$13.32$12.651.71 million shs$1.22 billion03/06/2024$11.73$12.13+3.41%$12.26$11.841.65 million shs$1.13 billion03/05/2024$13.77$11.73-14.81%$13.77$11.621.51 million shs$1.09 billion03/04/2024$12.62$13.77+9.11%$16.63$13.506.10 million shs$1.28 billion03/01/2024$11.47$12.62+10.03%$13.34$11.762.26 million shs$1.18 billion02/29/2024$11.76$11.47-2.47%$12.28$11.431.29 million shs$1.07 billion02/28/2024$11.74$11.76+0.17%$12.09$11.59830,817 shs$1.10 billion02/27/2024$11.03$11.74+6.44%$11.79$10.981.12 million shs$1.09 billion02/26/2024$11.18$11.03-1.34%$11.47$10.761.28 million shs$1.03 billion02/23/2024$10.59$11.18+5.57%$11.42$10.601.21 million shs$1.04 billion02/22/2024$10.46$10.59+1.24%$11.07$10.371.08 million shs$987.09 million02/21/2024$9.89$10.46+5.76%$10.52$9.861.01 million shs$974.98 million02/20/2024$9.74$9.89+1.54%$9.99$9.63695,364 shs$921.85 million02/19/2024$9.74$9.74$9.90$9.49991,400 shs$907.87 million02/16/2024$9.79$9.74-0.51%$9.90$9.49991,399 shs$907.87 million02/15/2024$9.80$9.79-0.10%$9.96$9.591.29 million shs$912.49 million02/14/2024$8.85$9.80+10.73%$10.12$8.791.40 million shs$913.42 million02/13/2024$9.38$8.85-5.65%$9.01$8.651.65 million shs$824.91 million02/12/2024$8.45$9.38+11.01%$9.40$8.441.61 million shs$874.31 million02/09/2024$8.45$8.45$8.56$8.281.44 million shs$787.59 million02/08/2024$8.34$8.45+1.32%$8.63$8.01898,806 shs$787.62 million Related Companies: Enliven Therapeutics Stock Price Chart Arcutis Biotherapeutics Stock Price Chart Tango Therapeutics Stock Price Chart Zentalis Pharmaceuticals Stock Price Chart Sage Therapeutics Stock Price Chart Immunome Stock Price Chart ARS Pharmaceuticals Stock Price Chart OPKO Health Stock Price Chart ALX Oncology Stock Price Chart Longboard Pharmaceuticals Stock Price Chart Receive ETNB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for 89bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ETNB) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 89bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.